搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
dmac
/
财务摘要
DiaMedica Therapeutics Inc
DMAC
添加自选
6.550
USD
+0.080
+1.24%
收盘 09-11 16:00(美东)
353.21M
总市值
亏损
市盈率 TTM
DiaMedica Therapeutics Inc
6.550
+0.080
+1.24%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
DMAC 财务数据
通过专为投资者打造的一站式数据看板,全面查看 DiaMedica Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
353.21M
股息TTM
0.00
市盈率 TTM
-9.30
每股收益TTM
-0.70
营业收入
--
净利润
-24.44M
净资产收益率
-86.47%
总资产收益率
-76.38%
DiaMedica Therapeutics Inc 财报日历
最新发布
8月 10, 2026
每股收益 / 预测值
-0.19
/-0.20
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-4.97%
-0.19
-3.77%
-0.19
9.65%
-0.17
-15.84%
-0.17
-33.28%
-0.18
-32.56%
-0.18
-35.93%
-0.18
-24.56%
-0.15
17.97%
-0.13
31.92%
-0.14
4.29%
-0.14
--
-0.12
--
-0.16
--
-0.20
--
-0.14
--
--
--
--
--
--
--
--
--
--
净利润
-31.69%
-10.14M
-30.30%
-10.04M
-10.63%
-8.74M
--
--
-50.40%
-7.70M
-49.62%
-7.71M
-53.07%
-7.90M
-40.33%
-6.27M
-14.34%
-5.12M
2.30%
-5.15M
-37.59%
-5.16M
-46.16%
-4.47M
-33.32%
-4.48M
-50.29%
-5.27M
-15.56%
-3.75M
11.33%
-3.06M
--
-3.36M
3.15%
-3.51M
22.71%
-3.25M
-8.05%
-3.45M
资产负债率
-68.53%
0.02%
-60.10%
0.02%
-54.69%
0.02%
-44.10%
0.03%
16.41%
0.06%
830.38%
0.06%
629.91%
0.05%
519.88%
0.05%
383.95%
0.05%
-79.55%
0.01%
-74.58%
0.01%
--
0.01%
--
0.01%
--
0.03%
--
0.03%
--
--
--
--
--
--
--
--
--
--
利润表
营业利润
-31.11%
-10.50M
-28.71%
-10.48M
-9.43%
-9.21M
-31.24%
-9.03M
-42.02%
-8.01M
-41.86%
-8.14M
-43.96%
-8.42M
-33.47%
-6.88M
-18.92%
-5.64M
-3.98%
-5.74M
-47.19%
-5.85M
-64.87%
-5.16M
-40.93%
-4.74M
-56.14%
-5.52M
-22.40%
-3.97M
8.43%
-3.13M
--
-3.36M
2.29%
-3.54M
23.95%
-3.25M
-3.70%
-3.42M
净利润
-31.69%
-10.14M
-30.30%
-10.04M
-10.63%
-8.74M
--
--
-50.40%
-7.70M
-49.62%
-7.71M
-53.07%
-7.90M
-40.33%
-6.27M
-14.34%
-5.12M
2.30%
-5.15M
-37.59%
-5.16M
-46.16%
-4.47M
-33.32%
-4.48M
-50.29%
-5.27M
-15.56%
-3.75M
11.33%
-3.06M
--
-3.36M
3.15%
-3.51M
22.71%
-3.25M
-8.05%
-3.45M
资产负债表
流动资产
42.59%
44.31M
39.93%
52.36M
35.91%
60.63M
10.75%
56.22M
-43.51%
31.08M
-21.19%
37.42M
-16.89%
44.61M
6.02%
50.77M
33.43%
55.01M
60.02%
47.48M
58.64%
53.67M
31.23%
47.89M
5.25%
41.23M
-29.53%
29.67M
-25.54%
33.84M
-24.82%
36.49M
81.11%
39.17M
74.05%
42.11M
62.74%
45.44M
56.04%
48.54M
流动负债总额
60.20%
6.59M
23.22%
5.75M
-4.79%
5.13M
22.60%
5.27M
33.29%
4.12M
78.26%
4.67M
93.47%
5.39M
98.02%
4.30M
58.68%
3.09M
-7.00%
2.62M
28.51%
2.79M
40.73%
2.17M
26.69%
1.95M
96.23%
2.81M
42.26%
2.17M
-5.05%
1.54M
6.67%
1.54M
21.73%
1.43M
-24.85%
1.52M
12.54%
1.62M
总资产
43.00%
45.00M
36.70%
53.08M
32.42%
61.37M
8.61%
57.05M
-44.59%
31.47M
-21.17%
38.83M
-14.43%
46.34M
-9.66%
52.52M
-8.48%
56.79M
63.02%
49.26M
57.46%
54.16M
56.96%
58.14M
58.06%
62.05M
-28.41%
30.22M
-24.49%
34.40M
-23.88%
37.04M
80.30%
39.26M
73.31%
42.21M
62.13%
45.55M
55.63%
48.66M
总负债
54.95%
6.66M
19.87%
5.84M
-6.52%
5.26M
18.97%
5.42M
27.37%
4.30M
67.50%
4.88M
81.34%
5.63M
81.67%
4.56M
46.34%
3.38M
-8.89%
2.91M
20.83%
3.10M
27.93%
2.51M
49.51%
2.31M
121.41%
3.19M
68.17%
2.57M
20.52%
1.96M
5.98%
1.54M
19.16%
1.44M
-26.62%
1.53M
7.67%
1.63M
总权益
41.10%
38.34M
39.11%
47.23M
37.80%
56.11M
7.63%
51.62M
-49.13%
27.17M
-26.74%
33.95M
-20.25%
40.72M
-13.78%
47.96M
-10.59%
53.41M
71.52%
46.35M
60.42%
51.06M
58.58%
55.63M
58.41%
59.74M
-33.72%
27.02M
-27.71%
31.83M
-25.42%
35.08M
85.62%
37.72M
76.14%
40.77M
69.23%
44.02M
58.06%
47.04M
现金流量表
经营净额
-6.79%
-8.11M
-27.04%
-9.08M
-20.69%
-7.76M
-515.79%
-27.53M
-68.13%
-7.60M
-7.46%
-7.15M
-68.78%
-6.43M
6.82%
-4.47M
10.16%
-4.52M
-30.73%
-6.65M
-37.82%
-3.81M
-103.18%
-4.80M
-101.52%
-5.03M
-30.89%
-5.09M
1.36%
-2.77M
22.49%
-2.36M
-19.48%
-2.50M
9.85%
-3.89M
7.03%
-2.80M
-29.78%
-3.05M
投资净额
-7.97%
8.24M
-131.92%
-2.11M
53.60%
8.00M
3.46%
-5.39M
89.13%
8.96M
57.37%
6.62M
-15.01%
5.21M
-566.97%
-5.58M
116.84%
4.74M
67.72%
4.21M
29.64%
6.12M
-42.28%
1.20M
-1212.66%
-28.13M
13.32%
2.51M
154.37%
4.72M
116.15%
2.07M
155.61%
2.53M
24700.00%
2.21M
-1402.70%
-8.69M
8.37%
-12.83M
融资净额
-18.01%
132.00K
358.24%
417.00K
9975.83%
12.09M
25536.59%
31.53M
-98.63%
161.00K
9200.00%
91.00K
12100.00%
120.00K
2150.00%
123.00K
-68.11%
11.75M
0.00%
-1.00K
0.00%
-1.00K
-200.00%
-6.00K
1842600.00%
36.85M
0.00%
-1.00K
94.74%
-1.00K
-100.01%
-2.00K
-100.00%
-2.00K
-100.41%
-1.00K
51.28%
-19.00K
40.95%
29.86M
常见问题
DiaMedica Therapeutics Inc的流动资产是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,流动资产为60.63M(同比变化35.91)。
DiaMedica Therapeutics Inc的总资产是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,DiaMedica Therapeutics Inc的总资产为61.37M(同比变化32.42)。
DiaMedica Therapeutics Inc的总负债是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,DiaMedica Therapeutics Inc的总负债为5.26M(同比变化-6.52)。
DiaMedica Therapeutics Inc的总权益是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,DiaMedica Therapeutics Inc的总权益为56.11M(同比变化37.80)。
DiaMedica Therapeutics Inc的净营业收入是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,DiaMedica Therapeutics Inc的净营业收入为-34.40M(同比变化-28.92)。
DiaMedica Therapeutics Inc的净投资是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,DiaMedica Therapeutics Inc的净投资为-2.19M(同比变化-125.60)。
DiaMedica Therapeutics Inc的净融资是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,DiaMedica Therapeutics Inc的净融资为43.88M(同比变化265.82)。
DiaMedica Therapeutics Inc的每股收益(EPS)是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.70(同比变化-15.28)。
DiaMedica Therapeutics Inc的净利润是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,净利润为-32.77M(同比变化-34.05)。
DiaMedica Therapeutics Inc的债务与资产比率是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,债务与资产比率为0.02(同比变化-54.69)。
DiaMedica Therapeutics Inc的股东权益回报率(ROE)是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-67.68(同比变化-27.05)。
DiaMedica Therapeutics Inc的资产回报率(ROA)是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,资产回报率(ROA)为-60.84(同比变化-25.07)。
DiaMedica Therapeutics Inc的营业利润是多少?
根据DiaMedica Therapeutics Inc的FY2025财报,营业利润为-34.40M(同比变化-28.92)。